Meeting the unmet needs of patients with new medicines | Ep22

<p>Andy Yates Chief Scientific officer at Artelo Biosciences joins the show this week to share his story as well as the innovative programmes Artelo are currently running.</p> <p> </p> <p>Find out how after dropping out of school at 16 Andy went on to do a Pharmacy degree and later a PhD which helped him explore his love of science and drug development.</p> <p> </p> <p>Andy and the team at Artelo have been exploring the endocannabinoid therapeutic potential.</p> <p> </p> <p>Tune in to hear about the various drugs Artelo have formulated including one to treat Cancer Anorexia and Cachexia Syndrome (CACS).</p> <p>To contact Andy email him at <a href='mailto:andy@artelobio.com'>andy@artelobio.com</a></p> <p>Connect on LinkedIn <a href='https://www.linkedin.com/in/andy-y-4985aa1/'>https://www.linkedin.com/in/andy-y-4985aa1/</a></p> <p>Check out their website <a href='https://artelobio.com/who-we-are/'>https://artelobio.com/who-we-are/</a></p> <p> </p> <p> </p>